• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Stock

Pharma giant Roche pledges $50 billion US investment in R&D, manufacturing

by April 22, 2025
by April 22, 2025

Swiss pharmaceutical giant Roche unveiled ambitious plans on Tuesday for a substantial $50 billion investment in the United States over the coming five years.

This significant commitment represents one of the largest recent inward investment declarations by a multinational corporation navigating the complexities of current US trade policies, including tariffs implemented under the Trump administration.

The comprehensive investment strategy is set to generate considerable employment opportunities across the country.

Roche detailed that the $50 billion infusion would lead to the creation of more than 12,000 new jobs.

This figure includes nearly 6,500 positions related to construction activities and an additional 1,000 permanent roles at newly established and expanded company facilities.

Strategic investment in a shifting trade environment

Roche’s announcement comes at a time when various global manufacturers, particularly within the pharmaceutical sector, are reassessing their supply chains and investment footprints in response to the Trump administration’s focus on tariffs and boosting domestic production.

This move mirrors a similar declaration earlier this month by fellow Swiss drugmaker Novartis, which committed to spending $23 billion on expanding and building new facilities within the United States.

Expanding US footprint: R&D and manufacturing focus

The scope of Roche’s investment is extensive, targeting key areas of its operations.

The company specified that the funds will support the development of new research and development (R&D) sites.

Furthermore, significant capital will be allocated to expanding existing manufacturing capabilities in several states, including Indiana, Pennsylvania, Massachusetts, and California.

This broad geographic spread underscores a deep commitment to enhancing Roche’s operational base within the US.

Aiming for net export status from the US

A key strategic outcome articulated by Roche is a fundamental shift in its US trade balance.

The company stated that once the new and expanded manufacturing capacities become fully operational, it anticipates exporting more medicines from the United States than it imports.

This signals a long-term vision for the US serving as a major global supply hub for the company’s products.

Underscoring the significance of the plan, Roche Chief Executive Thomas Schinecker emphasized the company’s dedication to the American market.

“Our investments of $50 billion over the next five years will lay the foundation for our next era of innovation and growth, benefiting patients in the US and around the world,” Schinecker said in a statement, framing the investment as crucial for future advancements and patient access globally.

The post Pharma giant Roche pledges $50 billion US investment in R&D, manufacturing appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Here’s why I’d sell SCHD and JEPI ETFs and buy UTF instead
next post
Is Novo Nordisk falling behind Eli Lilly in the weight-loss drug race?

Related Posts

Cristiano Ronaldo joins the billionaire club, net worth...

October 8, 2025

Elon Musk’s xAI secures $20B boost as Nvidia,...

October 8, 2025

SoftBank to acquire ABB’s robotics unit for $5.4B...

October 8, 2025

European stocks open higher: CAC 40 climbs 0.11%,...

October 8, 2025

EU steel tariff surge threatens UK exports and...

October 8, 2025

Why Tata Motors stock remains in the red...

October 8, 2025

Asian markets open: Nikkei hits another record high,...

October 7, 2025

Top reasons why the Topix and Nikkei 225...

October 7, 2025

Goldman Sachs boosts 2026 gold price forecast to...

October 7, 2025

Beijing intensifies oil stockpiling amid global supply and...

October 7, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • Sateliot and Nordic Enable First 5G IoT Link from LEO Satellites

    October 8, 2025
  • Have Mount Laurel Obligations Made New Jersey Housing More Affordable? A Synthetic Control Analysis of Housing Supply and Cost

    October 8, 2025
  • Rent Control Will Make the Housing Crisis Worse

    October 8, 2025
  • Gold’s Acceleration Reveals Vanishing Calm, Coming Change

    October 8, 2025
  • Why the Erosion of Central Bank Independence Matters

    October 8, 2025
  • Cristiano Ronaldo joins the billionaire club, net worth hits $1.4B

    October 8, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025
  • 5

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 6

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025
  • 7

    Pop Mart reports 188% profit surge, plans aggressive global expansion

    March 26, 2025

Categories

  • Economy (2,816)
  • Editor's Pick (281)
  • Investing (185)
  • Stock (1,920)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

Asian markets open: Nikkei tumbles 1.4%, Sensex...

August 14, 2025

DAX Index analysis: Why German stocks are...

October 7, 2025

China’s heatwave fuels record power demand, strains...

July 17, 2025